Effect of HER3 Overexpression on Survival Outcomes in Pancreatic Cancer Patients: A Systematic Review and Meta-Analysis
In summary, our results reveal that a significant proportion of PC patients show overexpression of HER3, suggesting its potential role as a target for immunotherapy. The findings also highlight the promise of HER3 as a prognostic biomarker in PC.
Authors
- Masoud Hassanzadeh Makoui (ORCID: https://orcid.org/0000-0002-0821-4420)
- N. El Ansari (ORCID: https://orcid.org/0000-0003-2263-359X)
- Reza Hassanzadeh Makoui (ORCID: https://orcid.org/0000-0001-6673-6692)
- Zahra Jafari (ORCID: https://orcid.org/0000-0002-7188-2755)
- Shiva Fekri (ORCID: https://orcid.org/0009-0008-1435-9053)
- Shima Shokrzadeh
Institutions
- Zanjan University of Medical Sciences (IR)
- University of Tabriz (IR)
Publication Details
- Journal
- Asian Pacific Journal of Cancer Prevention
- Published
- 2025-09-01
- DOI
- https://doi.org/10.31557/apjcp.2025.26.9.3175
- Citations
- 1
- Primary Topic
- HER2/EGFR in Cancer Research
- Type
- article
- Field-Weighted Citation Impact
- 1.05